$DVAX
DYNAVAX TECHNOLOGIES CORP

2022 Q3 Form 10-Q Financial Statement

#000095017022014735 Filed on August 04, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $167.7M $256.5M $114.0M
YoY Change 54.92% 386.03% 36.79%
Cost Of Revenue $61.33M $83.37M $39.96M
YoY Change 2.07% 461.6% 62.25%
Gross Profit $106.4M $173.1M $74.03M
YoY Change 120.84% 356.45% 26.09%
Gross Profit Margin 63.43% 67.49% 64.94%
Selling, General & Admin $32.04M $36.18M $32.17M
YoY Change 19.0% 67.63% 43.48%
% of Gross Profit 30.11% 20.9% 43.46%
Research & Development $12.96M $9.689M $11.10M
YoY Change 109.54% 35.19% 43.01%
% of Gross Profit 12.18% 5.6% 14.99%
Depreciation & Amortization $890.0K $1.100M $985.0K
YoY Change -17.44% 0.73% -11.26%
% of Gross Profit 0.84% 0.64% 1.33%
Operating Expenses $45.00M $45.87M $43.27M
YoY Change 35.91% 59.54% 43.36%
Operating Profit $61.40M $128.2M $30.76M
YoY Change 282.11% 1298.03% 7.83%
Interest Expense $1.685M $1.683M $1.680M
YoY Change 0.54% -45.87% -64.35%
% of Operating Profit 2.74% 1.31% 5.46%
Other Income/Expense, Net -$208.0K $40.00K $105.0K
YoY Change -187.39% -123.12% -81.15%
Pretax Income $64.09M $129.4M $32.86M
YoY Change -325.44% 2792.33% 3592.02%
Income Tax $300.0K $600.0K $0.00
% Of Pretax Income 0.47% 0.46% 0.0%
Net Earnings $63.81M $128.8M $32.86M
YoY Change -324.44% 2778.49% 3587.88%
Net Earnings / Revenue 38.04% 50.2% 28.83%
Basic Earnings Per Share $0.50 $1.02 $0.26
Diluted Earnings Per Share $0.43 $0.87 $0.22
COMMON SHARES
Basic Shares Outstanding 126.5M 126.3M 124.6M
Diluted Shares Outstanding 151.5M 149.9M 149.4M

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $586.5M $518.2M $503.2M
YoY Change 41.61% 49.84% 116.25%
Cash & Equivalents $198.6M $249.1M $179.4M
Short-Term Investments $387.9M $269.1M $323.8M
Other Short-Term Assets $112.7M $189.0M $221.3M
YoY Change -34.02% 313.14% 426.96%
Inventory $102.6M $73.98M $79.04M
Prepaid Expenses
Receivables $129.8M $172.3M $134.0M
Other Receivables $1.346M $1.972M $2.968M
Total Short-Term Assets $932.9M $955.4M $940.5M
YoY Change 9.41% 63.62% 119.99%
LONG-TERM ASSETS
Property, Plant & Equipment $35.35M $36.29M $36.41M
YoY Change 3.21% -37.12% 18.61%
Goodwill $1.835M $1.958M $2.082M
YoY Change -15.48%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $3.337M $3.363M $3.447M
YoY Change -7.89% -17.31% -11.62%
Total Long-Term Assets $66.39M $67.59M $68.46M
YoY Change -0.97% 5.61% 9.42%
TOTAL ASSETS
Total Short-Term Assets $932.9M $955.4M $940.5M
Total Long-Term Assets $66.39M $67.59M $68.46M
Total Assets $999.3M $1.023B $1.009B
YoY Change 8.66% 57.89% 105.87%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.050M $4.959M $20.19M
YoY Change -15.18% -58.95% 531.06%
Accrued Expenses $38.21M $34.15M $16.11M
YoY Change -56.54% 2.33% -27.77%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $244.1M $345.2M $466.2M
YoY Change -53.85% 68.68% 326.15%
LONG-TERM LIABILITIES
Long-Term Debt $221.3M $221.0M $220.8M
YoY Change 0.49% 0.49% 22.71%
Other Long-Term Liabilities $251.0K $295.0K $276.0K
YoY Change 217.72% -99.79% -90.49%
Total Long-Term Liabilities $251.0K $295.0K $276.0K
YoY Change 217.72% -99.92% -90.49%
TOTAL LIABILITIES
Total Short-Term Liabilities $244.1M $345.2M $466.2M
Total Long-Term Liabilities $251.0K $295.0K $276.0K
Total Liabilities $498.8M $600.2M $721.5M
YoY Change -41.47% 6.32% 84.83%
SHAREHOLDERS EQUITY
Retained Earnings -$991.9M -$1.056B -$1.184B
YoY Change -24.69% -8.4%
Common Stock $1.502B $1.485B $1.476B
YoY Change 8.33% 5.89%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $500.6M $422.8M $287.5M
YoY Change
Total Liabilities & Shareholders Equity $999.3M $1.023B $1.009B
YoY Change 8.66% 57.89% 105.86%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income $63.81M $128.8M $32.86M
YoY Change -324.44% 2778.49% 3587.88%
Depreciation, Depletion And Amortization $890.0K $1.100M $985.0K
YoY Change -17.44% 0.73% -11.26%
Cash From Operating Activities $61.56M $16.65M -$50.44M
YoY Change -7.02% -84.97% -232.63%
INVESTING ACTIVITIES
Capital Expenditures -$1.281M -$2.913M $1.358M
YoY Change -64.7% 174.29% -22.27%
Acquisitions
YoY Change
Other Investing Activities -$117.8M $55.41M -$215.1M
YoY Change -338.87% -188.41% 929.8%
Cash From Investing Activities -$119.0M $52.50M -$216.5M
YoY Change -360.66% -182.35% 856.49%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 8.057M 1.028M 10.29M
YoY Change 51.39% -69.2% -68.15%
NET CHANGE
Cash From Operating Activities 61.56M 16.65M -50.44M
Cash From Investing Activities -119.0M 52.50M -216.5M
Cash From Financing Activities 8.057M 1.028M 10.29M
Net Change In Cash -49.43M 70.18M -256.8M
YoY Change -142.17% 39.32% -646.66%
FREE CASH FLOW
Cash From Operating Activities $61.56M $16.65M -$50.44M
Capital Expenditures -$1.281M -$2.913M $1.358M
Free Cash Flow $62.84M $19.56M -$51.80M
YoY Change -10.02% -82.51% -242.76%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0001029142
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-34207
dei Entity Registrant Name
EntityRegistrantName
Dynavax Technologies Corporation
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
33-0728374
dei Entity Address Address Line1
EntityAddressAddressLine1
2100 Powell Street
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 720
dei Entity Address City Or Town
EntityAddressCityOrTown
Emeryville
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94608
dei City Area Code
CityAreaCode
510
dei Local Phone Number
LocalPhoneNumber
848-5100
dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value
dei Trading Symbol
TradingSymbol
DVAX
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
73764000
CY2022Q2 us-gaap Assets Current
AssetsCurrent
955405000
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
126473586
CY2022Q2 us-gaap Goodwill
Goodwill
1958000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
972520000
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
36286000
CY2021Q4 us-gaap Goodwill
Goodwill
2125000
CY2022Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
202000
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
249091000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
436189000
CY2022Q2 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
269078000
CY2021Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
109761000
CY2022Q2 us-gaap Other Receivables
OtherReceivables
1972000
CY2021Q4 us-gaap Other Receivables
OtherReceivables
15600000
CY2022Q2 us-gaap Inventory Net
InventoryNet
73979000
CY2021Q4 us-gaap Inventory Net
InventoryNet
61335000
CY2022Q2 dvax Prepaid Manufacturing
PrepaidManufacturing
54477000
CY2021Q4 dvax Prepaid Manufacturing
PrepaidManufacturing
159655000
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
134538000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
35020000
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
25785000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
25964000
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
219000
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3363000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3398000
CY2022Q2 us-gaap Assets
Assets
1022999000
CY2021Q4 us-gaap Assets
Assets
1039246000
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
4959000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2600000
CY2022Q2 dvax Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
3678000
CY2021Q4 dvax Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
4688000
CY2022Q2 dvax Coalition For Epidemic Preparedness Innovations Accruals
CoalitionForEpidemicPreparednessInnovationsAccruals
107370000
CY2021Q4 dvax Coalition For Epidemic Preparedness Innovations Accruals
CoalitionForEpidemicPreparednessInnovationsAccruals
128848000
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
34146000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
49796000
CY2022Q2 dvax Warrant Liability Current
WarrantLiabilityCurrent
0
CY2021Q4 dvax Warrant Liability Current
WarrantLiabilityCurrent
18016000
CY2022Q2 us-gaap Deferred Revenue
DeferredRevenue
191998000
CY2021Q4 us-gaap Deferred Revenue
DeferredRevenue
349864000
CY2022Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
3047000
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2590000
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
345198000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
556402000
CY2022Q2 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
4470000
CY2021Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
5010000
CY2022Q2 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
221030000
CY2021Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
220490000
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
33677000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
34316000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1441868000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
222374000
CY2022Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
295000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5664000
CY2022Q2 us-gaap Liabilities
Liabilities
600200000
CY2021Q4 us-gaap Liabilities
Liabilities
816872000
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
278000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
278000000
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
126439000
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
126439000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
122945000
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
122945000
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
126000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
123000
CY2022Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1484970000
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-6560000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2266000
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1055737000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1217351000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
422799000
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1022999000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1039246000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
256464000
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
52767000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
370456000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
136102000
CY2022Q2 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
83369000
CY2021Q2 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
14845000
us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
123331000
us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
39470000
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9689000
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7167000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
20784000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14925000
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
36179000
CY2021Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
21583000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
68351000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
44006000
CY2022Q2 us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
1000000
CY2021Q2 us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
0
us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
1000000
us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
0
CY2022Q2 us-gaap Costs And Expenses
CostsAndExpenses
128237000
CY2021Q2 us-gaap Costs And Expenses
CostsAndExpenses
43595000
us-gaap Costs And Expenses
CostsAndExpenses
211466000
us-gaap Costs And Expenses
CostsAndExpenses
98401000
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
128227000
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
9172000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1801000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
23455000
CY2022Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2021Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-5232000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
162233000
us-gaap Operating Income Loss
OperatingIncomeLoss
158990000
us-gaap Operating Income Loss
OperatingIncomeLoss
37701000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-5232000
CY2022Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0
CY2021Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-2097000
CY2022Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
765000
CY2021Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
48000
us-gaap Investment Income Interest
InvestmentIncomeInterest
1026000
us-gaap Investment Income Interest
InvestmentIncomeInterest
95000
CY2022Q2 us-gaap Interest Expense
InterestExpense
1683000
CY2021Q2 us-gaap Interest Expense
InterestExpense
3109000
us-gaap Interest Expense
InterestExpense
3363000
us-gaap Interest Expense
InterestExpense
7821000
CY2022Q2 us-gaap Sublease Income
SubleaseIncome
2025000
CY2021Q2 us-gaap Sublease Income
SubleaseIncome
1670000
us-gaap Sublease Income
SubleaseIncome
3634000
us-gaap Sublease Income
SubleaseIncome
3692000
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
40000
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-173000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
145000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
384000
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
129374000
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4473000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
5364000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
619000
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
619000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
128755000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
4473000
us-gaap Net Income Loss
NetIncomeLoss
161614000
us-gaap Net Income Loss
NetIncomeLoss
5364000
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.02
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.29
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.87
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.08
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
126347000
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
114629000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
125456000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
113339000
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
149905000
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
118830000
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2397000
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
413000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-4294000
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2397000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-986000
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
126358000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
128755000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
422799000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
149821000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
114978000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
128755000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
4473000
us-gaap Net Income Loss
NetIncomeLoss
161614000
us-gaap Net Income Loss
NetIncomeLoss
5364000
CY2022Q2 dvax Change In Unrealized Gain On Marketable Securities Available For Sale
ChangeInUnrealizedGainOnMarketableSecuritiesAvailableForSale
-629000
CY2021Q2 dvax Change In Unrealized Gain On Marketable Securities Available For Sale
ChangeInUnrealizedGainOnMarketableSecuritiesAvailableForSale
38000
dvax Change In Unrealized Gain On Marketable Securities Available For Sale
ChangeInUnrealizedGainOnMarketableSecuritiesAvailableForSale
-1901000
dvax Change In Unrealized Gain On Marketable Securities Available For Sale
ChangeInUnrealizedGainOnMarketableSecuritiesAvailableForSale
29000
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1768000
CY2021Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
375000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2393000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1015000
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
4886000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
157320000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
4378000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
287484000
CY2022Q2 dvax Issuance Withholding Of Common Stock Upon Exercise Of Options Vesting Of Restricted Stock Units And Vesting Of Early Exercised Options Net Value
IssuanceWithholdingOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsNetValue
1028000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7929000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
222374000
dvax Issuance Of Common Stock Upon Exercise Of Warrants
IssuanceOfCommonStockUponExerciseOfWarrants
24670000
dvax Issuance Withholding Of Common Stock Upon Exercise Of Options Vesting Of Restricted Stock Units And Vesting Of Early Exercised Options Net Value
IssuanceWithholdingOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsNetValue
2150000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
710000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
15575000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-4294000
us-gaap Net Income Loss
NetIncomeLoss
161614000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
422799000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
99762000
CY2021Q2 dvax Issuance Withholding Of Common Stock Upon Exercise Of Options Vesting Of Restricted Stock Units And Vesting Of Early Exercised Options Net Value
IssuanceWithholdingOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsNetValue
948000
CY2021Q2 dvax Adjustments To Additional Paid In Capital Purchase Of Capped Calls
AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCalls
-27240000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5024000
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
413000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
4473000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
83380000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
58693000
dvax Stock Issued Exercise Of Warrants During Period Value New Issues
StockIssuedExerciseOfWarrantsDuringPeriodValueNewIssues
7928000
dvax Issuance Withholding Of Common Stock Upon Exercise Of Options Vesting Of Restricted Stock Units And Vesting Of Early Exercised Options Net Value
IssuanceWithholdingOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsNetValue
1335000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
383000
dvax Issuance Of Common Stock Net Of Issuance Costs In Conjunction With An Underwritten Public Offering And An At Market Sales Agreement
IssuanceOfCommonStockNetOfIssuanceCostsInConjunctionWithAnUnderwrittenPublicOfferingAndAnAtMarketSalesAgreement
28156000
dvax Adjustments To Additional Paid In Capital Purchase Of Capped Calls
AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCalls
-27240000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9747000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-986000
us-gaap Net Income Loss
NetIncomeLoss
5364000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
83380000
us-gaap Net Income Loss
NetIncomeLoss
161614000
us-gaap Net Income Loss
NetIncomeLoss
5364000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2085000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2202000
dvax Amortization Of Right Of Use Assets And Loss On Disposal Of Property And Equipment
AmortizationOfRightOfUseAssetsAndLossOnDisposalOfPropertyAndEquipment
1644000
dvax Amortization Of Right Of Use Assets And Loss On Disposal Of Property And Equipment
AmortizationOfRightOfUseAssetsAndLossOnDisposalOfPropertyAndEquipment
1326000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
498000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-369000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-5232000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1801000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
23455000
us-gaap Share Based Compensation
ShareBasedCompensation
15575000
us-gaap Share Based Compensation
ShareBasedCompensation
9747000
dvax Non Cash Interest Expense
NonCashInterestExpense
540000
dvax Non Cash Interest Expense
NonCashInterestExpense
2806000
us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
1000000
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
42426000
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
83239000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
12644000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
22762000
dvax Increase Decrease In Prepaid Manufacturing
IncreaseDecreaseInPrepaidManufacturing
-105178000
dvax Increase Decrease In Prepaid Manufacturing
IncreaseDecreaseInPrepaidManufacturing
6875000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
60774000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
247000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-35000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
265000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2319000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
7209000
dvax Increase Decrease In Cepi Accrual
IncreaseDecreaseInCepiAccrual
-21478000
dvax Increase Decrease In Cepi Accrual
IncreaseDecreaseInCepiAccrual
0
dvax Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
1678000
dvax Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
1554000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-157866000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
91345000
dvax Long Term Deferred Revenue
LongTermDeferredRevenue
0
dvax Long Term Deferred Revenue
LongTermDeferredRevenue
106950000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-22617000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
7757000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-33792000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
148820000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
313660000
dvax Proceeds From Exercise Of Stock Options And Restricted Stock Awards Net
ProceedsFromExerciseOfStockOptionsAndRestrictedStockAwardsNet
2150000
dvax Proceeds From Exercise Of Stock Options And Restricted Stock Awards Net
ProceedsFromExerciseOfStockOptionsAndRestrictedStockAwardsNet
1335000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
164928000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
152950000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
710000
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
8455000
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
3376000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
97527000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
436408000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
81355000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4271000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2812000
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
1000000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-163981000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-86385000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
28156000
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
219822000
dvax Payments For Purchase Of Capped Call Options
PaymentsForPurchaseOfCappedCallOptions
0
dvax Payments For Purchase Of Capped Call Options
PaymentsForPurchaseOfCappedCallOptions
27240000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
190194000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
383000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
11315000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
35638000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-657000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-546000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-187115000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
32310000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
249293000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
129837000
us-gaap Income Taxes Paid
IncomeTaxesPaid
509000
us-gaap Income Taxes Paid
IncomeTaxesPaid
0
us-gaap Interest Paid Net
InterestPaidNet
2819000
us-gaap Interest Paid Net
InterestPaidNet
2053000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1214000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2131000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1767000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0
CY2022Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
0
CY2022Q2 us-gaap Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
337300000
us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.1260416666666666;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Use of Estimates</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make informed estimates and assumptions that may affect the amounts reported in the condensed consolidated financial statements and accompanying notes, including amounts of revenues and expenses during the reported periods. Management’s estimates are based on historical information available as of the date of the condensed consolidated financial statements and various other assumptions we believe are reasonable under the circumstances. On an ongoing basis, we evaluate our estimates, judgments and methodologies. Significant estimates and assumptions in the condensed consolidated financial statements include those related to revenue recognition; accounts receivable; useful lives of long-lived assets, impairment of long-lived assets, including goodwill; valuation procedures for right-of-use assets and operating lease liabilities; valuation of inventory; fair value of warrants; balance sheet classification of Convertible Notes; income taxes, including the valuation allowance for deferred tax assets; research and development expenses; contingencies and share-based compensation. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results may differ materially from these estimates under different assumptions or conditions and could be further impacted by the COVID-19 pandemic. Changes in estimates are reflected in reported results in the period in which they become known.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
CY2021Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
18016000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
-1801000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
16215000
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
249091000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
436189000
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
129608000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
32073000
CY2022Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
202000
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
219000
CY2021Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
229000
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
237000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
249293000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
436408000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
129837000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
32310000
CY2022Q2 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis
270968000
CY2022Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
270968000
CY2022Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
269078000
CY2022Q2 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
0
CY2022Q2 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
0
CY2022Q2 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
269078000
us-gaap Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
0
us-gaap Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
0
CY2022Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
32789000
CY2021Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
26637000
CY2022Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
18189000
CY2021Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
14748000
CY2022Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
23001000
CY2021Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
19950000
CY2022Q2 us-gaap Inventory Net
InventoryNet
73979000
CY2021Q4 us-gaap Inventory Net
InventoryNet
61335000
us-gaap Operating Lease Payments
OperatingLeasePayments
3400000
CY2022Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
1867000
CY2021Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
1570000
us-gaap Operating Lease Expense
OperatingLeaseExpense
3474000
us-gaap Operating Lease Expense
OperatingLeaseExpense
3130000
us-gaap Operating Lease Payments
OperatingLeasePayments
3500000
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3039000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2577000
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
33677000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
34316000
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
36716000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
36893000
CY2022Q2 dvax Lessor Sublease Rentals Payments To Be Received Remainder Of Fiscal Year
LessorSubleaseRentalsPaymentsToBeReceivedRemainderOfFiscalYear
2709000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
3195000
CY2022Q2 dvax Lessor Sublease Rentals Payments To Be Received Due Year Two
LessorSubleaseRentalsPaymentsToBeReceivedDueYearTwo
5518000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
6512000
CY2022Q2 dvax Lessor Sublease Rentals Payments To Be Received Due Year Three
LessorSubleaseRentalsPaymentsToBeReceivedDueYearThree
5684000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
6646000
CY2022Q2 dvax Lessor Sublease Rentals Payments To Be Received Due Year Four
LessorSubleaseRentalsPaymentsToBeReceivedDueYearFour
5854000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
6123000
CY2022Q2 dvax Lessor Sublease Rentals Payments To Be Received Due Year Five
LessorSubleaseRentalsPaymentsToBeReceivedDueYearFive
6030000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
5861000
CY2022Q2 dvax Lessor Sublease Rentals Payments To Be Received Due Thereafter
LessorSubleaseRentalsPaymentsToBeReceivedDueThereafter
27712000
CY2022Q2 dvax Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
27161000
CY2022Q2 dvax Lessor Sublease Rentals Payments To Be Received Due
LessorSubleaseRentalsPaymentsToBeReceivedDue
53507000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
55498000
CY2022Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
18782000
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
36716000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
128755000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
4473000
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P9Y1M6D
CY2022Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.101
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.101
CY2022Q2 us-gaap Purchase Obligation
PurchaseObligation
115700000
us-gaap Net Income Loss
NetIncomeLoss
161614000
CY2022Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P8Y3M
CY2022Q2 us-gaap Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
337300000
CY2022Q2 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
1409000
CY2021Q2 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
736000
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
2819000
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
736000
CY2022Q2 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
271000
CY2021Q2 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
137000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
540000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
137000
CY2022Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
1680000
CY2021Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
873000
us-gaap Interest Expense Debt
InterestExpenseDebt
3359000
us-gaap Interest Expense Debt
InterestExpenseDebt
873000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
256464000
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
52767000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
370456000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
136102000
us-gaap Net Income Loss
NetIncomeLoss
5364000
CY2022Q2 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
0
dvax Addition Of Undistributed Earnings Allocated To Participating Securities
AdditionOfUndistributedEarningsAllocatedToParticipatingSecurities
0
CY2022Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0
CY2022Q2 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
21543000
CY2021Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-2097000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1639000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1801000
CY2022Q2 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0
CY2021Q2 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
2571000
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
163000
CY2021Q2 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
-333000
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
-316000
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
-410000
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
128755000
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
4140000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
161298000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
4954000
CY2022Q2 dvax Addition Of Undistributed Earnings Allocated To Participating Securities
AdditionOfUndistributedEarningsAllocatedToParticipatingSecurities
0
CY2021Q2 dvax Addition Of Undistributed Earnings Allocated To Participating Securities
AdditionOfUndistributedEarningsAllocatedToParticipatingSecurities
0
dvax Addition Of Undistributed Earnings Allocated To Participating Securities
AdditionOfUndistributedEarningsAllocatedToParticipatingSecurities
316000
CY2022Q2 us-gaap Interest Expense Medium Term Notes
InterestExpenseMediumTermNotes
1260000
CY2021Q2 us-gaap Interest Expense Medium Term Notes
InterestExpenseMediumTermNotes
0
us-gaap Interest Expense Medium Term Notes
InterestExpenseMediumTermNotes
2519000
us-gaap Interest Expense Medium Term Notes
InterestExpenseMediumTermNotes
0
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
130015000
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
2043000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
162332000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
4954000
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
126347000
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
114629000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
125456000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
113339000
CY2022Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2015000
CY2021Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1630000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2659000
CY2021Q2 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0
us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
21543000
us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
149905000
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
118830000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
149821000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
114978000
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9647000
CY2021Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
22494000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9067000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
20803000
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
126439073
CY2019Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
18525000
CY2019Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q1 dvax Number Of Common Stock Warrant Exercised
NumberOfCommonStockWarrantExercised
1882600
CY2022Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
7929000
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
5024000
CY2022Q1 dvax Cash Settlement Of Warrants
CashSettlementOfWarrants
8500000
CY2022Q2 dvax Increase In Number Of Employee Stock Purchase Plan Shares Authorized For Issuance
IncreaseInNumberOfEmployeeStockPurchasePlanSharesAuthorizedForIssuance
15000000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
10399000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.55
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y1M28D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
42756000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2053000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
12.54
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
287000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
7.49
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
11526000
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.40
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y4M13D
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
31382000
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
11146000
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
11.37
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P4Y3M21D
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
30946000
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
6542000
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
11.52
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y1M2D
CY2022Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
21654000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
9747000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
600000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
15575000
CY2022Q2 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.004
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
600000
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.004

Files In Submission

Name View Source Status
0000950170-22-014735-index-headers.html Edgar Link pending
0000950170-22-014735-index.html Edgar Link pending
0000950170-22-014735.txt Edgar Link pending
0000950170-22-014735-xbrl.zip Edgar Link pending
dvax-20220630.htm Edgar Link pending
dvax-20220630.xsd Edgar Link pending
dvax-20220630_cal.xml Edgar Link unprocessable
dvax-20220630_def.xml Edgar Link unprocessable
dvax-20220630_htm.xml Edgar Link completed
dvax-20220630_lab.xml Edgar Link unprocessable
dvax-20220630_pre.xml Edgar Link unprocessable
dvax-ex31_1.htm Edgar Link pending
dvax-ex31_2.htm Edgar Link pending
dvax-ex32_1.htm Edgar Link pending
dvax-ex32_2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending